- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 614501, 5 pages
Antimicrobial Activity of Lippia Species from the Brazilian Semiarid Region Traditionally Used as Antiseptic and Anti-Infective Agents
1Laboratório de Química de Produtos Naturais e Bioativos, Departamento de Ciências Exatas, Universidade Estadual de Feira de Santana, Avenida Transnordestina S/N, Bairro Novo Horizonte, Campus Universitário, 44036-900 Feira de Santana, BA, Brazil
2Laboratório de Microbiologia da Agroindústria, Universidade Estadual de Santa Cruz, Campus Soane Nazaré de Andrade, Km 16 Rodovia Ilhéus-Itabuna, 45662-900 Ilhéus, BA, Brazil
3Departamento de Ciências Biológicas, Universidade Estadual de Feira de Santana, Avenida Transnordestina S/N, Bairro Novo Horizonte, Campus Universitário, 44036-900 Feira de Santana, BA, Brazil
Received 15 July 2013; Accepted 7 August 2013
Academic Editor: Vincenzo De Feo
Copyright © 2013 Cristiana da Purificação Pinto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Lippia origanoides Kunth, Lippia alnifolia Schauer, and Lippia thymoides Martius and Schauer are shrubs used in the traditional Brazilian medicine as antiseptics, as well as in the treatment of infectious diseases. This study was designed to investigate the antibacterial and antifungal activities of the methanolic extracts of these species, as new potential sources of antimicrobial drugs. The antimicrobial activity of methanolic extracts was investigated against resistant yeasts and bacteria by agar disk diffusion. Then, the MIC determination of the most active species and its fractions in hexane, dichloromethane, ethyl acetate, and water was performed. By the agar diffusion assay, all species were active against at least two microorganisms, giving evidence to support their use in the popular medicine. L. origanoides leaves exhibited the widest antimicrobial action, inhibiting the growth of two Gram-positive bacteria and two yeasts; this activity was also confirmed by the MIC evaluation. The fractionation of L. origanoides crude extracts improved the activity in spectrum and intensity. The results obtained in this study indicate that L. origanoides may be a promising alternative in the treatment of bacterial and fungal infections and in the seeking of new antimicrobial drugs.
The development and spread of antimicrobial resistance is a worldwide concern, due to the negative impacts on public health . Therefore, there is a growing need for novel drugs against bacterial, fungal, and viral infections. The traditional knowledge on the therapeutic potential of plants has been attracting scientific interest seeking new ways to control and treat many diseases caused by microorganisms [2–4].
The genus Lippia has a great number of medicinal species, such as L. origanoides Kunth, L. alnifolia Schauer, and L. thymoides Martius and Schauer, which are frequently used in folk medicine for the treatment of microbial diseases . In Brazil, L. origanoides is popularly known as “salva-de-Marajó and “alecrim d’Angola.” The leaf infusions are used as a general antiseptic for the mouth, throat, and wounds, for the treatment of baby colic, diarrhea, indigestion, flatus, heartburn, nausea, vaginal discharges, menstrual complaints, and fever [5, 6]. L. alnifolia is also known as “alecrim-do-mato,” “pedrécio,” and “alecrim-de-vaqueiro.” The leaves are employed as a topic antiseptic against dermatitis and dandruff, as well as an oral antiseptic and in vaginal infections [7, 8]. Aerial parts of L. thymoides, known as “alecrim-do-mato,” are used in the treatment of skin infections .
Although the traditional use of these plants, studies supporting the antibiotic activity of L. alnifolia and L. thymoides are not found in the literature. Antimicrobial activity has been reported to L. origanoides, though it was related to the leaf essential oils [7, 9–11]. Therefore, a bioprospecting study was designed to investigate the antimicrobial activities of L. alnifolia, L. origanoides, and L. thymoides extracts from the Brazilian semiarid region against bacteria and yeasts, in order to select the most active species.
2. Materials and Methods
2.1. Plant Material
Aerial parts of L. alnifolia (LA), L. origanoides (LO), and L. thymoides (LT) were collected in October 2006, in the city of Rio de Contas, BA, Brazil. Samples were identified by Dr. Tânia Regina dos Santos Silva, from Universidade Estadual de Feira de Santana. Voucher specimens were deposited at the UEFS herbarium, under the registry numbers HUEFS 112586, HUEFS 112591, and HUEFS 112597, respectively.
2.2. Extracts Preparation
The air dried and powdered stems, leaves, and flowers were macerated in methanol for 10 days at room temperature. Extraction was repeated at least five times, and the filtrates of all portions were combined. The solvent was removed by evaporation under vacuum on reduced pressure at 40–45°C using a rotary evaporator. Water residues were removed by lyophilization and packed in a glass pot to store in a refrigerator.
2.3. Fractions Preparation
The dry methanolic crude extracts (20 g) were resuspended in a methanol : water solution (1 : 1) and extracted with hexane (3 × 500 mL). After methanol removal by evaporation, the residual aqueous solution was subjected to a sequential partition with dichloromethane (3 × 500 mL) and ethyl acetate (3 × 500 mL). The solvent of each fraction, including the final aqueous fraction, was removed as described above.
2.4. Antimicrobial Activity
The antimicrobial effect of various extract samples was assayed against Staphylococcus aureus CCMB262 (streptomycin and dihydrostreptomycin resistant), Staphylococcus aureus CCMB263 (novobiocin resistant), Bacillus cereus CCMB 282, Escherichia coli CCMB261 (sulfonamide resistant), Pseudomonas aeruginosa CCMB268, Candida albicans CCMB266 (fluconazole and amphotericin B resistant), and Candida parapsilosis CCMB 288 (fluconazole and amphotericin B resistant) from the Culture Collection of Microorganisms of Bahia (CCMB).
2.4.2. Agar Disk Diffusion Method (ADD)
A screening for antimicrobial activity was performed by Agar Disk Diffusion method, according to the Clinical and Laboratory Standards Institute , with some modifications. Methanolic solutions of the extracts at 200 mg·mL−1 were sterilized by filtration through a 0.22 μm membrane filter. Filter paper disks ( 6 mm) were impregnated with 5 μL of each extract solution (1 mg of crude extract/disk), and the methanol was evaporated at room temperature for 2 h. The microorganisms were grown on Agar Type 1 Himedia-RM 666 and Mueller Hinton Himedia-M391 broth. After 18 h (bacteria) and 36 h (yeast), the inoculum was adjusted to 5 × 105 UFC·mL−1 and 1.5 × 108 UFC·mL−1, respectively, in saline solution at 0.45%. Microorganism suspensions (100 μL) were uniformly spread in Petri plates containing Mueller-Hinton Agar. The paper disks impregnated with the samples were placed on the surface of the agar. The plates were incubated at 28°C/48 h and 37°C/18 24 h for yeasts and bacteria, respectively. Inhibition zones (mm) were measured, and a positive result was considered with halos larger than 6.5 mm (disk diameter included). Nystatin (10 μg/disk), erythromycin, and chloramphenicol (30 μg/disk) were used as positive controls against yeasts and bacteria. The tests were done in triplicate.
2.4.3. Minimum Inhibitory Concentration (MIC) Tests
The determination of the Minimum Inhibitory Concentration was performed as described in the CLSI [13, 14], with modifications. The extracts or fractions (42 mg) solubilized in DMSO 50% were sterilized by filtration through a 0.22 μm membrane filter. In 96-well plates, 95 μL of extracts solution and 95 μL of Mueller-Hinton broth (2X concentrated) were conditioned in the first well, and the seriated dilutions were carried out in all subsequent wells. The range of evaluated extract concentration was from 21.05 mg·mL−1 to 0.01 mg·mL−1. Cultures of 18 h (bacteria) and 36 h (yeast) were collected to saline solution 0.45%, and 5 μL of microorganism suspension at 9 × 106 UFC·mL−1 and 5 × 105 UFC·mL−1 (bacteria and yeasts, resp.) was added in each well. The microplates were incubated at 28°C/48 h for yeasts and 37°C/24 h for bacteria. An aqueous solution of 2,3,5-triphenyltetrazolium chloride (50 μL at 5 mg·mL−1) for yeasts or rezasurin (30 μL at 0,1 mg·mL−1) for bacteria was added in all wells. The result was read after 3 h of incubation, and red wells were considered an indication of microbial growth. The MIC was defined as the lowest concentration in which there was no visible growth after incubation. Controls with nystatin for yeasts (10 mg·mL−1) and chloramphenicol (20 mg·mL−1) for bacteria were made. Controls of the microbial strains viability, sample sterility, and water were also performed. The MIC of the DMSO solution in water (50%) was also determined. All tests were done in triplicate. Plant extracts with MICs ≤2.631 mg·mL−1 were considered active antimicrobial agents.
2.5. Phytochemical Screening
A phytochemical screening was performed on all fractions of L. origanoides by thin layer chromatography, according to the procedure described in the TLC Atlas “Plant Drug Analysis” .
3. Results and Discussion
The disk diffusion assay results are summarized in Table 1. All extracts have shown antimicrobial activity, inhibiting at least one of the evaluated microorganisms, as for the flowers and stems extracts of L. thymoides. A wide spectrum antimicrobial activity was noted with L. origanoides leaves, inhibiting the growth of two S. aureus strains, in addition to C. albicans and C. parapsilosis.
S. aureus CCMB262 was the most sensitive strain concerning theantibacterial effect of the extracts (seven out of eight extracts were active), whereas E. coli and P. aeruginosa were the least sensitive microorganisms (all extracts inactive). In general, the Gram-positive bacteria were the most sensitive to the tested methanolic extracts, with inhibition zones of 6.9 to 12.3 mm. This higher resistance of Gram-negative bacteria was expected, due to the polysaccharide outer membrane with a lower permeability and efflux pumps. This system prevents the accumulation of the antimicrobial agent inside the cell, thus impeding the substance from reaching its target or the concentration becoming lethal to the cell .
Despite the low permeability of the fungal cell walls, composed of 1,3-β-glucan and chitin polymers , an anticandidal activity was observed in L. alnifolia flowers, as well as in L. origanoides leaves. C. parapsilosis was the most sensitive yeast, which was inhibited by two out of eight extracts.
L. origanoides was selected for further assays (fractionation by liquid-liquid partition, MIC determination, and phytochemical screening) because of its wide spectrum of antimicrobial activity. The MIC determination (Table 2) showed that leaf crude extracts also inhibited the microbial growth of all evaluated Gram-positive bacteria and yeasts (MIC ranging from 2.631 to 0.658 mg·mL−1), in agreement with the antimicrobial results by the previous ADD test. However, stem methanol extracts, although inactive in the ADD assay, showed action against S. aureus CCMB263 and C. albicans, in the latter with MIC values similar to those obtained by the leaf extracts. The reason for the difference in sensitivity between the two methods might be related to diffusion properties of the antimicrobial compounds from the extracts into the agar and adsorption in the paper disk .
The fractions from leaves and stems exhibited varying degrees of antimicrobial action, with hexane and ethyl acetate fractions from leaves showing the highest antibacterial effect against S. aureus (MIC—0.329 mg·mL−1). An enhanced activity against all microorganisms was observed with the fractionation, including against E. coli, to which the extracts were considered inactive. Dichloromethane fractions from leaves and stems, as well as the ethyl acetate fraction from leaves, were the most efficient against E. coli (MIC—0.658 mg·mL−1). The best result against C. albicans was obtained by the dichloromethane fraction from the stems (MIC—0.658 mg·mL−1), a noteworthy result considering that invasive candidiasis is a leading cause of mycosis-mortality .
The results of phytochemical screening of L. origanoides fractions showed the presence of terpenes, steroids, coumarins, saponins, flavonoids, and phenolic acids in stems and leaves, while alkaloids were absent (Table 3). These phytoconstituents, common in Lippia , are recognized as antimicrobial agents against several bacteria and yeasts . Terpenes were the predominant metabolites in the hexane fractions and flavonoids in ethyl acetate fractions. These constituents may be the responsible for the improved antibacterial activity in hexane and ethyl acetate fractions.
The antimicrobial activity by ADD gives preliminary scientific evidence to the traditional use of L. alnifolia, L. origanoides, and L. thymoides as antiseptic agents and in the treatment of infectious diseases. Although the results of this study suggest the antibacterial potential of three evaluated species, the L. origanoides leaves exhibited the widest antimicrobial action being a promising alternative in the treatment of bacterial and fungal infections. As the fractionation of L. origanoides crude extracts improved the activity in spectrum and intensity, further investigations are in progress to isolate and characterize the active metabolites.
Conflict of Interests
The authors have declared that they have no conflict of interests.
The authors thank the Instituto do Milênio do Semiárido and Conselho Nacional de Desenvolvimento Científico e Tecnológico (IMSEAR/CNPq) for the financial support, Fundação de Amparo a Pesquisa do Estado da Bahia (FAPESB) for the financial support, Universidade Estadual de Feira de Santana for the fellowship granted to Velize D. Rodrigues, and CNPQ for the fellowship granted to Tânia Regina dos Santos Silva.
- WHO, The Evolving Threat of Antimicrobial Resistance—Options for Action, WHO Press, Geneva, Switzerland, 2012.
- T. Sibanda and A. I. Okoh, “The challenges of overcoming antibiotic resistance: plant extracts as potential sources of antimicrobial and resistance modifying agents,” African Journal of Biotechnology, vol. 6, no. 25, pp. 2886–2896, 2007.
- R. W. Bussmann, G. Malca-García, A. Glenn et al., “Minimum inhibitory concentrations of medicinal plants used in Northern Peru as antibacterial remedies,” Journal of Ethnopharmacology, vol. 132, no. 1, pp. 101–108, 2010.
- N. W. Vogel, A. P. D. Taschetto, R. Dall'Agnol, L. Weidlich, and E. M. Ethur, “Assessment of the antimicrobial effect of three plants used for therapy of community-acquired urinary tract infection in Rio Grande do Sul (Brazil),” Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1334–1336, 2011.
- M. E. Pascual, K. Slowing, E. Carretero, D. S. Mata, and A. Villar, “Lippia: traditional uses, chemistry and pharmacology: a review,” Journal of Ethnopharmacology, vol. 76, no. 3, pp. 201–214, 2001.
- D. R. Oliveira, G. G. Leitão, H. R. Bizzo et al., “Chemical and antimicrobial analyses of essential oil of Lippia origanoides H.B.K,” Food Chemistry, vol. 101, no. 1, pp. 236–240, 2007.
- L. S. Funch, R. Harley, R. Funch, et al., Plantas Úteis: Chapada Diamantina, Rima, São Carlos, Brazil, 2004.
- M. D. F. Agra, K. N. Silva, I. J. L. D. Basílio, P. F. de Freitas, and J. M. Barbosa-Filho, “Survey of medicinal plants used in the region Northeast of Brazil,” Brazilian Journal of Pharmacognosy, vol. 18, no. 3, pp. 472–508, 2008.
- F. J. B. dos Santos, J. A. D. Lopes, A. M. G. L. Cito, E. H. de Oliveira, S. G. de Lima, and F. D. A. M. Reis, “Composition and biological activity of essential oils from Lippia origanoides H.B.K,” Journal of Essential Oil Research, vol. 16, no. 5, pp. 504–506, 2004.
- L. S. Ramírez, J. Isaza, L. A. Veloza, E. Stashenko, and D. Marín, “Actividad antibacteriana de aceites esenciales de Lippia origanoides de diferentes orígenes de Colombia,” Ciencia, vol. 17, no. 4, pp. 313–321, 2009.
- V. Tangarife-Castaño, J. Correa-Royero, B. Zapata-Londoño, C. Durán, E. Stanshenko, and A. C. Mesa-Arango, “Anti-Candida albicans activity, cytotoxicity and interaction with antifungal drugs of essential oils and extracts from aromatic and medicinal plants,” Infection, vol. 15, no. 13, pp. 160–167, 2011.
- Clinical and Laboratory Standards Institute (CLSI), Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard, M2-A8, CLSI, Pennsylvania, Pa, USA, 8th edition, 2003.
- Clinical and Laboratory Standards Institute (CLSI), Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard, M7-A6, CLSI, Pennsylvania, Pa, USA, 6th edition, 2003.
- Clinical and Laboratory Standards Institute (CLSI), Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard, M27-A2, CLSI, Pennsylvania, Pa, USA, 2nd edition, 2002.
- H. Wagner, S. Bladt, and E. M. Zgainsk, Plant Drug Analysis. A Thin Layer Chromatography Atlas, Springer, Berlin, Germany, 1984.
- J. Hoskins, W. E. Alborn Jr., J. Arnold et al., “Genome of the bacterium Streptococcus pneumoniae strain R6,” Journal of Bacteriology, vol. 183, no. 19, pp. 5709–5717, 2001.
- J.-P. Latgé, “The cell wall: a carbohydrate armour for the fungal cell,” Molecular Microbiology, vol. 66, no. 2, pp. 279–290, 2007.
- C. Valgas, S. M. de Souza, E. F. A. Smânia, and A. Smânia Jr., “Screening methods to determine antibacterial activity of natural products,” Brazilian Journal of Microbiology, vol. 38, no. 2, pp. 369–380, 2007.
- M. A. Pfaller and D. J. Diekema, “Epidemiology of invasive candidiasis: a persistent public health problem,” Clinical Microbiology Reviews, vol. 20, no. 1, pp. 133–163, 2007.
- M. M. Cowan, “Plant products as antimicrobial agents,” Clinical Microbiology Reviews, vol. 12, no. 4, pp. 564–582, 1999.